News

We are looking back at the ICRS 2023 meeting in Sitges, Spain last week.

We will be present at the LSI Europe 2023. We look forward o discussing how these great ideas and innovations can come to live and how LifeTec Group can accelerate these developments with our BioSimulation platforms. 

We will support the wet-lab sessions with our Cardiac BioSimulator at Focus Valve 2023, for the fifth time. Focus Valve is the accredited training course for minimally invasive heart valve surgery, this year taking place from September 10th to 13th in Innsbruck.

We will be showcasing our Osteochondral Platform at ICRS 2023, a major event in the field of cartilaginous tissue research and joint preservation taking place in Sitges from September 9th to 12th. Join the In Vitro Models session on the 10th at 13:15 in Tramuntana 3 to learn more about our innovative technologies and to connect with our team.

We will showcase our Cardiac BioSimulator at the ESC Amsterdam Conference, allowing attendees to experience realistic cardiac training, including echo techniques and 3D skills with Philips, while also supporting GE HealthCare with an interactive session on Transesophageal Echocardiography (TEE) assessment.

The time has come to say goodbye to Davy and Alicia!

We're proud that our work has contributed to a new publication! It reports the development of the MarioHeart in-vitro model by researchers of the Eindhoven University of Technology and the University Medical Center Utrecht, in collaboration with LifeTec Group, which enables the testing of thrombogenicity of mechanical heart valve prostheses and potential anticoagulant therapies through its unique design and realistic flow simulation.

We are delighted to share that LifeTec Group is to be part of the NXTGEN HIGHTECH program. By participating in this initiative, we will unite with esteemed industry pioneers and renowned educational institutions to address pressing societal challenges and position The Netherlands at the forefront of the global high-tech industry.

Our Cardiac BioSimulator has once again played a crucial role in a recent publication. This publication outlines an ex vivo cardiac study conducted to examine the potential of intravalvular impedance (IVI) measurements in a sensorized biological heart valve prosthesis.